A risk-based modeling approach for radiation therapy treatment planning under tumor shrinkage uncertainty

Gino J. Lim, Laleh Kardar, Saba Ebrahimi, Wenhua Cao

Research output: Contribution to journalArticle

Abstract

Robust optimization approaches have been widely used to address uncertainties in radiation therapy treatment planning problems. Because of the unknown probability distribution of uncertainties, robust bounds may not be correctly chosen, and a risk of undesirable effects from worst-case realizations may exist. In this study, we developed a risk-based robust approach, embedded within the conditional value-at-risk representation of the dose-volume constraint, to deal with tumor shrinkage uncertainty during radiation therapy. The objective of our proposed model is to reduce dose variability in the worst-case scenarios as well as the total delivered dose to healthy tissues and target dose deviations from the prescribed dose, especially, in underdosed scenarios. We also took advantage of adaptive radiation therapy in our treatment planning approach. This fractionation technique considers the response of the tumor to treatment up to a particular point in time and reoptimizes the treatment plan using an estimate of tumor shrinkage. The benefits of our model were tested in a clinical lung cancer case. Four plans were generated and compared: static, nominal-adaptive, robust-adaptive, and conventional robust (worst-case) optimization. Our results showed that the robust-adaptive model, which is a risk-based model, achieved less dose variability and more control on the worst-case scenarios while delivering the prescribed dose to the tumor target and sparing organs at risk. This model also outperformed other models in terms of tumor dose homogeneity and plan robustness.

Original languageEnglish (US)
Pages (from-to)266-278
Number of pages13
JournalEuropean Journal of Operational Research
Volume280
Issue number1
DOIs
StatePublished - Jan 1 2020

Fingerprint

Radiation Therapy
Radiotherapy
Shrinkage
Tumors
Tumor
Dose
Planning
Uncertainty
Modeling
Scenarios
Model
Fractionation
Conditional Value at Risk
Probability distributions
Target
Robust Optimization
Radiation
Therapy
Lung Cancer
Homogeneity

Keywords

  • CVaR
  • OR in medicine
  • Radiation therapy planning
  • Risk management
  • Tumor shrinkage

ASJC Scopus subject areas

  • Computer Science(all)
  • Modeling and Simulation
  • Management Science and Operations Research
  • Information Systems and Management

Cite this

A risk-based modeling approach for radiation therapy treatment planning under tumor shrinkage uncertainty. / Lim, Gino J.; Kardar, Laleh; Ebrahimi, Saba; Cao, Wenhua.

In: European Journal of Operational Research, Vol. 280, No. 1, 01.01.2020, p. 266-278.

Research output: Contribution to journalArticle

@article{9bd85d1fd2e94633afdbcc1dcc3c1842,
title = "A risk-based modeling approach for radiation therapy treatment planning under tumor shrinkage uncertainty",
abstract = "Robust optimization approaches have been widely used to address uncertainties in radiation therapy treatment planning problems. Because of the unknown probability distribution of uncertainties, robust bounds may not be correctly chosen, and a risk of undesirable effects from worst-case realizations may exist. In this study, we developed a risk-based robust approach, embedded within the conditional value-at-risk representation of the dose-volume constraint, to deal with tumor shrinkage uncertainty during radiation therapy. The objective of our proposed model is to reduce dose variability in the worst-case scenarios as well as the total delivered dose to healthy tissues and target dose deviations from the prescribed dose, especially, in underdosed scenarios. We also took advantage of adaptive radiation therapy in our treatment planning approach. This fractionation technique considers the response of the tumor to treatment up to a particular point in time and reoptimizes the treatment plan using an estimate of tumor shrinkage. The benefits of our model were tested in a clinical lung cancer case. Four plans were generated and compared: static, nominal-adaptive, robust-adaptive, and conventional robust (worst-case) optimization. Our results showed that the robust-adaptive model, which is a risk-based model, achieved less dose variability and more control on the worst-case scenarios while delivering the prescribed dose to the tumor target and sparing organs at risk. This model also outperformed other models in terms of tumor dose homogeneity and plan robustness.",
keywords = "CVaR, OR in medicine, Radiation therapy planning, Risk management, Tumor shrinkage",
author = "Lim, {Gino J.} and Laleh Kardar and Saba Ebrahimi and Wenhua Cao",
year = "2020",
month = "1",
day = "1",
doi = "10.1016/j.ejor.2019.06.041",
language = "English (US)",
volume = "280",
pages = "266--278",
journal = "European Journal of Operational Research",
issn = "0377-2217",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A risk-based modeling approach for radiation therapy treatment planning under tumor shrinkage uncertainty

AU - Lim, Gino J.

AU - Kardar, Laleh

AU - Ebrahimi, Saba

AU - Cao, Wenhua

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Robust optimization approaches have been widely used to address uncertainties in radiation therapy treatment planning problems. Because of the unknown probability distribution of uncertainties, robust bounds may not be correctly chosen, and a risk of undesirable effects from worst-case realizations may exist. In this study, we developed a risk-based robust approach, embedded within the conditional value-at-risk representation of the dose-volume constraint, to deal with tumor shrinkage uncertainty during radiation therapy. The objective of our proposed model is to reduce dose variability in the worst-case scenarios as well as the total delivered dose to healthy tissues and target dose deviations from the prescribed dose, especially, in underdosed scenarios. We also took advantage of adaptive radiation therapy in our treatment planning approach. This fractionation technique considers the response of the tumor to treatment up to a particular point in time and reoptimizes the treatment plan using an estimate of tumor shrinkage. The benefits of our model were tested in a clinical lung cancer case. Four plans were generated and compared: static, nominal-adaptive, robust-adaptive, and conventional robust (worst-case) optimization. Our results showed that the robust-adaptive model, which is a risk-based model, achieved less dose variability and more control on the worst-case scenarios while delivering the prescribed dose to the tumor target and sparing organs at risk. This model also outperformed other models in terms of tumor dose homogeneity and plan robustness.

AB - Robust optimization approaches have been widely used to address uncertainties in radiation therapy treatment planning problems. Because of the unknown probability distribution of uncertainties, robust bounds may not be correctly chosen, and a risk of undesirable effects from worst-case realizations may exist. In this study, we developed a risk-based robust approach, embedded within the conditional value-at-risk representation of the dose-volume constraint, to deal with tumor shrinkage uncertainty during radiation therapy. The objective of our proposed model is to reduce dose variability in the worst-case scenarios as well as the total delivered dose to healthy tissues and target dose deviations from the prescribed dose, especially, in underdosed scenarios. We also took advantage of adaptive radiation therapy in our treatment planning approach. This fractionation technique considers the response of the tumor to treatment up to a particular point in time and reoptimizes the treatment plan using an estimate of tumor shrinkage. The benefits of our model were tested in a clinical lung cancer case. Four plans were generated and compared: static, nominal-adaptive, robust-adaptive, and conventional robust (worst-case) optimization. Our results showed that the robust-adaptive model, which is a risk-based model, achieved less dose variability and more control on the worst-case scenarios while delivering the prescribed dose to the tumor target and sparing organs at risk. This model also outperformed other models in terms of tumor dose homogeneity and plan robustness.

KW - CVaR

KW - OR in medicine

KW - Radiation therapy planning

KW - Risk management

KW - Tumor shrinkage

UR - http://www.scopus.com/inward/record.url?scp=85068040657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068040657&partnerID=8YFLogxK

U2 - 10.1016/j.ejor.2019.06.041

DO - 10.1016/j.ejor.2019.06.041

M3 - Article

VL - 280

SP - 266

EP - 278

JO - European Journal of Operational Research

JF - European Journal of Operational Research

SN - 0377-2217

IS - 1

ER -